Dantas Machado, Ana Carolina
Ramos, Stephany Flores http://orcid.org/0000-0002-1918-9769
Gauglitz, Julia M.
Fassler, Anne-Marie
Petras, Daniel http://orcid.org/0000-0002-6561-3022
Aksenov, Alexander A.
Kim, Un Bi
Lazarowicz, Michael
Barnard Giustini, Abbey
Aryafar, Hamed
Vodkin, Irine
Warren, Curtis
Dorrestein, Pieter C. http://orcid.org/0000-0002-3003-1030
Zarrinpar, Ali
Zarrinpar, Amir http://orcid.org/0000-0001-6423-5982
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (K08 DK102902, R03 DK114536, R21 MH117780, R01 EB030134, P30 DK120515, P30 DK063491, P30 CA014195, P50 AA011999, UL1 TR001442)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
UC | UC San Diego | Kavli Institute for Brain and Mind, University of California, San Diego
Article History
Received: 23 January 2023
Accepted: 9 August 2023
First Online: 31 August 2023
Competing interests
: Am.Z. is a co-founder, acting chief medical officer, and equity-holder in Endure Biotherapeutics. P.C.D. is a scientific advisor and holds equity to Cybele and a Co-founder, advisor and holds equity in Ometa, Arome and Enveda with prior approval by UC-San Diego and consulted in 2023 for DSM animal health. A.A.A. is a founder of Arome Science Inc. The remaining authors declare no competing interests.